Respiratory physiology & neurobiology · 2026
Ventilatory limitation to exercise in patients with HFpEF and obesity: No room to breathe.
Клиническое исследованиеСтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Babb Tony G, Balmain Bryce N, Tomlinson Andrew R, Hynan Linda S, Levine Benjamin D, MacNamara James P, Sarma Satyam
Аннотация
BACKGROUND: Lowering pulmonary capillary wedge pressure (PCWP) by sublingual nitroglycerin (NTG) fails to increase exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF). These findings beg the question as to the origin of exercise limitation. Our objective was to determine whether exercise tolerance could be ventilatory limited in older patients with HFpEF and obesity.
METHODS: Patients with HFpEF and obesity (n = 42) underwent pulmonary artery and radial artery catheterizations. Cardiorespiratory responses, breathing mechanics, and arterial blood gases were measured at rest, 20 W, and at peak exercise before and after NTG.
RESULTS: At rest, there was a drop in cardiac output and PaO2 (p < 0.01) with subsequent increases in HR, a-v¯O2 difference, and A-aO2 difference (p < 0.001) after NTG. At 20 W, there were increases in HR, a-v¯O2 difference, V̇E/V̇CO2, lactate, PaO2, and A-aO2 difference (p < 0.05). At peak exercise, there was an increase in V̇E/V̇CO2 and pH (p < 0.01), and a decrease in PaCO2 (p < 0.001). However, before and after treatment, there was a qualitative decline in V̇E/V̇CO2 from 20 W to peak exercise suggesting these patients could not increase V̇E further. There were no differences in breathing mechanics at rest, 20 W, or peak exercise after NTG.
CONCLUSIONS: We conclude that mechanical ventilatory constraints coupled with increased ventilatory inefficiency impose a ventilatory limitation to exercise in patients with HFpEF and obesity.
CLINICAL TRIAL INFORMATION: Clinical Trials number: NCT04068844.
METHODS: Patients with HFpEF and obesity (n = 42) underwent pulmonary artery and radial artery catheterizations. Cardiorespiratory responses, breathing mechanics, and arterial blood gases were measured at rest, 20 W, and at peak exercise before and after NTG.
RESULTS: At rest, there was a drop in cardiac output and PaO2 (p < 0.01) with subsequent increases in HR, a-v¯O2 difference, and A-aO2 difference (p < 0.001) after NTG. At 20 W, there were increases in HR, a-v¯O2 difference, V̇E/V̇CO2, lactate, PaO2, and A-aO2 difference (p < 0.05). At peak exercise, there was an increase in V̇E/V̇CO2 and pH (p < 0.01), and a decrease in PaCO2 (p < 0.001). However, before and after treatment, there was a qualitative decline in V̇E/V̇CO2 from 20 W to peak exercise suggesting these patients could not increase V̇E further. There were no differences in breathing mechanics at rest, 20 W, or peak exercise after NTG.
CONCLUSIONS: We conclude that mechanical ventilatory constraints coupled with increased ventilatory inefficiency impose a ventilatory limitation to exercise in patients with HFpEF and obesity.
CLINICAL TRIAL INFORMATION: Clinical Trials number: NCT04068844.